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The objective of this study was to determine the role of endoscopic Nd:YAG laser treat-
ment in the preoperative or postoperative management of tracheobronchoplasty.
Eighteen patients with severe stenotic lesions of the trachea or bronchus underwent
Nd:YAG laser treatment. Nd:YAG laser treatment was performed in the preoperative
period in 14 patients and in the postoperative period in 4 patients. The indications for
Nd:YAG laser treatment included emergency airway dilatation, confirmation of the dis-
tal margin of tumor, and safe tracheal intubation in patients with severe tracheal steno-
sis. The indications for Nd:YAG laser treatment in patients with severe stenosis of the
mainstem bronchus were confirmation of the distal margin of tumor and recovery of
lung ventilation during the preoperative period and reopening of the bronchial lumen to
prevent obstructive pneumonia in the postoperative period. Among patients treated with
Nd:YAG laser preoperatively, the indications were completely achieved in all 14
patients, except for 1 patient with adenoid cystic carcinoma who underwent treatment of
the right mainstem bronchus. Among patients treated with Nd:YAG laser postopera-
tively the indications also were achieved in all 4 patients with severe granulomatous
stenosis of the bronchial end-to-end anastomosis following sleeve lobectomy. In conclu-
sion, endoscopic Nd:YAG laser treatment played an important role in the perioperative
management of patients undergoing tracheobronchoplasty.
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INTRODUCTION
Tracheobronchoplasty has become an established
operative method for the preservation of lung
function in patients with benign or malignant dis-
eases of the trachea or bronchus [1,2]. Severe tra-
cheal stenosis, however, may require urgent air-
way reopening as a lifesaving measure. Stenosis of
the anastomotic site of the tracheobronchoplasty
also may occur. The optimal management modal-
ity for these perioperative problems remains to be
determined [3].
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In this study, we evaluated the role of endoscopic
Nd:YAG laser treatment in the perioperative manage-
ment of tracheobronchoplasty in patients with benign
and malignant tracheobronchial stenosis.
MATERIALS AND METHODS
Patients
Among 50 patients undergoing tracheal or bronchial
plasty, 18 patients were treated with endoscopic
Nd:YAG laser treatment preoperatively or postopera-
tively and were included in this study (Table I). The
operation performed for tracheobronchoplasty con-
sisted of tracheal sleeve resection with end-to-end
anastomoses in 8 patients, sleeve lobectomies in 8
patients, sleeve lobectomy and carinal reconstruction
in 1 patient, and bronchial sleeve resection in 1
patient.
Method ofNd:YAG Laser Irradiation
Endoscopic Nd:YAG laser treatment was performed
according to the method previously described [4].
Nd:YAG laser (Medilas YAG, MBB Co., Germany)
treatment was performed by a noncontact method at
TABLE Patient Characteristics
Characteristic No. of Patients
















ACC, adenoid cystic carcinoma; SCC, squamous cell
carcinoma
approximately 30 to 50 W for 1 sec intermittently
through a quartz fiber covered with a Teflon tube 2.0
mm in diameter inserted via a biopsy channel of a
bronchofiberscope. All patients were treated under
local anesthesia with 10 ml of 4% lidocaine
hydrochloride after administration of 0.5 mg of
atropine sulfate and 15 to 30 mg of pentazosin. When
Nd:YAG laser treatment was performed for severe tra-
cheal stenosis, tumor vaporization was performed at
the same time from the surface of the airway. During
the firstNd:YAG laser treatment, an attempt to reopen
the tracheal lumen to greater than 6.0 mm in diameter
so that a bronchoscope of 6.0 mm in outer diameter
could be placed to relieve wheezing and dyspnea. The
tracheal lumen was reopened to 8 to 10 mm in diame-
ter during the following two to five sessions of
Nd:YAG laser treatment.
Indications for and Effects ofNd:YAG Laser
Treatment
In patients with severe tracheocarinal stenosis, indica-
tions for preoperative Nd:YAG laser treatment
included lifesaving airway reopening, confirmation of
the distal margin of tumor, and safe endotracheal intu-
bation for general anesthesia. In patients with bronchial
stenosis, indications for preoperative Nd:YAG laser
treatment consisted of airway reopening for the confir-
mation of the distal margin of tumor and recovery of
ventilation. In patients treated with the Nd:YAG laser
postoperatively, airway reopening was the indication.
Efficacy was defined as "effective" when the indica-
tions were achieved, with reopening of lumen diame-
ter 6 mm or more and improved lung function
parameters, and "ineffective" when the indications
were not achieved, without reopening of lumen diam-
eter 6 mm or more and without improved lung func-
tion parameters.
RESULTS
Of the 8 patients treated with the Nd:YAG laser pre-
operatively for tracheocarinal stenosis (Table II), the
chief complaints were severe dyspnea and wheezing.ND: YAG LASER TREATMENT IN TRACHEOBRONCHOPLASTY 55
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Significant improvements of forced expiratory vol-
ume 1.0 and peak expiratory flow rate and possible
improvement of forced vital capacity and forced
expiratory volume 1.0% were demonstrated. The
indications for endoscopic Nd:YAG laser treatment
were completely achieved in all 8 patients. All
patients were alive and were able to resume good
daily life activity.
Among 6 patients with bronchial stenosis (Table
III), the indications for endoscopic Nd:YAG laser
treatment were achieved in 5 patients. However, in a
patient with adenoid cystic carcinoma, continuous
bleeding from the irradiated sites forced the cessation
of Nd:YAG laser treatment, and bleeding stopped
spontaneously approximately 5 minutes later. The
patient underwent right sleeve pneumonectomy and
patient died from dehiscence of the anastomosis
between the trachea and left mainstem bronchus 1
month postoperatively.
In patients treated with the Nd:YAG laser postoper-
atively (Table IV), significant improvement of airway
reopening was demonstrated in all 4 patients. Two
patients died at 12 and 36 months after Nd:YAG laser
treatment, and the other 2 patients were alive without
restenosis of the anastomotic site at 5 and 7 years after
Nd:YAG laser treatment. No complications occurred
except for a patient with continuous bleeding in this
series of the study.
Case Report
T.S., a 65-year-old woman was seen with chief com-
plaints of wheezing, dyspnea, and bloody sputum. In
April 1991, her symptoms gradually worsened, and
she was admitted to our department in May.
Bronchofiberscopic findings revealed a polypoid type
tumor occupying approximately 90% of the tracheal
lumen at the first cartilaginous ring below the vocal
cord (Fig. 1A). Two sessions of endoscopic Nd:YAG
laser treatment (first: 6010 J, second: 6324 J) were
performed as an emergency treatment. The tracheal
lumen was reopened to 10 mm (Fig. 1B), and her
symptoms completely disappeared. The longitudinal
distance of invasion along the trachea was 3.5 cm, and
the distal margin of tumor was located at the 13th car-
tilaginous ring from the carina. Biopsy specimens
revealed adenoid cystic carcinoma. Induction for gen-
eral anesthesia was performed with routine muscle
relaxants, and a spiral tube (12 mm in outer diameter)
was intubated intratracheally without difficulty. Four
centimeters of trachea including six cartilaginous
rings were resected, and an end-to-end anastomosis
was performed with 3-0 absorbable synthetic sutures.
Pathologic examination demonstrated adenoid cystic
carcinoma with residual cancer cells at the resected
superior margins. The postoperative course was
uneventful, and a total of 60 Gy of radiotherapy was
TABLE III Endoscopic Nd:YAG Laser Surgery Before Sleeve Lobectomy or Sleeve Pneumonectomy
Patient Age (yr)/Sex Histology No. Sessions Total J Effectiveness Survival
K.M. 42/M Adenocarcinoma 2 7,904 Effective 8 mo dead
F.M. 67/M SCC 4,850 Effective 2 mo dead
T.A. 65/F ACC 715 Ineffective mo dead
T.M. 41/M SCC 1,888 Effective 7 yr alive
S.M. 69/M SCC 2 10,547 Effective 3 mo alive
I.T. 36/M Carcinoid 4 25,206 Effective 30 mo alive
TABLE IV Endoscopic Nd:YAG Laser Surgery After Sleeve Lobectomy
Patient Age (yr)/Sex Disease No. Sessions Total J Effectiveness Survival
T.K. 56/M Granulation 3 4,347 Effective 36 mo dead
T.S. 65/M Granulation 3 12,787 Effective 60 mo alive
M.K. 53/M Granulation 2 2,624 Effective 48 mo alive
S.A. 72/M Granulation 338(CT) Effective 12 mo dead
CT, contact tip.ND: YAG LASER TREATMENT IN TRACHEOBRONCHOPLASTY 57
FIGURE A. Bronchofiberscopic findings revealed a protruding tumor with superficial blood vessel dilatation obstructing approximately
90% of the tracheal lumen. B. After two sessions of Nd:YAG laser treatment, the tracheal lumen was reopened to approximately 10 mm in
diameter. Symptoms completely disappeared, and the distal margin of tumor at the 13th cartilaginous ring from the carina was confirmed by
bronchoscopy.58 T. FUJISAWA et al.
added postoperatively. The patient is in good physical
condition without any clinical sign of recurrence 48
months postoperatively.
DISCUSSION
Reconstruction of the trachea or bronchus has pro-
gressed remarkably in the last decade as a surgical
technique for the preservation of lung function and
urgent airway dilatation in patients with severe steno-
sis of the airway. Previously, emergency radical oper-
ation or blind intubation with a slender tracheal tube
beyond the stenotic portion were necessary. In emer-
gency surgery, tracheal intubation under local anes-
thesia with the patient awake was performed because
of the difficulties with lung ventilation after the
administration of muscle relaxant. These techniques
were burdensome not only for patients but also for
anesthesiologists. With blind intubation with a tra-
cheal tube, there was the possibility of massive bleed-
ing causing fatal complications and safer management
of severe stenosis of airway was required.
Since 1981, we have treated patients with benign or
malignant lesions with endoscopic Nd:YAG laser
treatment. The indications included palliative irradia-
tion for airway reopening and hemostasis in unre-
sectable advanced disease, airway reopening before
and after surgical treatment and curative irradiation
for superficial carcinomas. The effects of palliation of
the airway have previously been reported [5-7]; how-
ever, few reports have documented the significance of
endoscopic Nd:YAG laser treatment in the periopera-
tive period of tracheobronchoplastic surgery.
In this article, we found significant results with pre-
operative irradiation in patients with tracheal stenosis.
Endoscopic Nd:YAG laser treatment could reopen the
tracheal lumen preoperatively and contribute to the
improvement of the general condition of the patients.
Further, this procedure permitted the surgeon to con-
firm the distal margin of tumor and to safely intubate
under routine general anesthesia with the use of mus-
cle relaxant. Endoscopic Nd:YAG laser treatment is
an effective preoperative procedure in patients with
severe tracheal stenosis. However, the long-term sur-
vival demonstrated in this study is considered to be
due to the effect of surgery and the histologic type of
cancer instead of the effect of endoscopic treatment.
Endoscopic Nd:YAG laser treatment is also effective
in the preoperative period in patients with hilar type
bronchogenic carcinomas, because it allowed better
assessment of the possible resection margins before
sleeve lobectomy was performed. Stenoses due to gran-
ulation tissue formation of bronchial end-to-end anasto-
moses can be reopened by Nd:YAG laser treatment in
patients undergoing sleeve lobectomy, and its effect is
maintained for a long period when the granulomatous
tissue is confined within 10mm in longitudinal width.
Endoscopic Nd:YAG laser treatment is recommended
before thoracotomy is perfo.rmed to remove stenosis of
the bronchial anastomosis. Kato and co-workers [8]
reported the significance of preoperative laser photody-
namic therapy in combination with surgery for lung can-
cer, and this article stressed the importance ofNd:YAG
laser therapy in the management of tracheoplasty.
As previously reported [9,10], endoscopic Nd:YAG
laser treatment can be associated with major compli-
cations including massive bleeding or perforation if
not performed properly. Nd:YAG laser treatment must
be confined to a lesion within cartilaginous rings. In a
sleeve lobectomy for patients with granulomatous
stenosis at the end-to-end anastomosis of the
bronchus, endoscopic Nd:YAG laser treatment should
be performed with consideration of mediastinal
anatomy and the site of both the anastomosis and pul-
monary artery. A tracheobronchial stenting procedure
has been reported as an additional endoscopic treat-
ment alternative before or after Nd:YAG laser [11].
We have not yet applied stenting in this study; how-
ever, stenting is considered to be useful for stenosis of
bronchial anastomosis in sleeve lobectomy.
The optimal interval between endoscopic Nd:YAG
laser treatment and tracheobronchoplasty remains
uncertain; however, we demonstrated that bronchial
epithelium damaged with 150 J of irradiation could
heal within 2 weeks. It may be considered that tra-
cheobronchoplasty can be performed 2 weeks after the
last session of Nd:YAG laser treatment. Preoperative
management, including airway cleaning by nebulizer
and systemic administration of antibiotics, is required.ND: YAG LASER TREATMENT IN TRACHEOBRONCHOPLASTY 59
In conclusion, endoscopic Nd:YAG laser treatment
is considered to be very effective for emergency air-
way reopening, confirmation of the distal margin of
tumor, and safe tracheal intubation as the periopera-
tive management of tracheoplasty in patients with
stenoses of trachea or mainstem bronchus.
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